Learn how Huntsman Cancer Institute uses cutting‑edge diagnostics and personalized care to treat early‑stage prostate cancer. Discover why early detection makes treatment more effective and far less ...
Baseline T may provide valuable information about prognosis.
A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to a new study led by investigators at Weill Cornell Medicine and Beth Israel ...
In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...
Prostate cancer is the most common cancer in men throughout the United States. Most men do not realize they have cancer due ...
Stockhead on MSN
Health Check: Telix jumps first hurdle with its advanced prostate cancer therapy trial
In welcome good news, Telix says the first stage of its pivotal prostate cancer therapeutic trial has hit its desired safety ...
Maurice Blake says he never knew that one-in-four black men face prostate cancer - double the average.
In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...
Adelaide newsreader Will McDonald has managed his aggressive stage 4 prostate cancer for six years now, although he knows the intensive drug regime he is on, while doing the trick for now, won’t last ...
Dr Fred Saad of the University of Montreal discusses the future direction of alpha emitter agents in the treatment of prostate cancer, emphasizing the logical progression of resea ...
Oxybutynin significantly reduced hot flash frequency and severity compared with placebo among men with prostate cancer ...
Graham Heron from Dorset urges UK men to get PSA tests for early prostate cancer detection, credits Dorchester Hospital and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results